Description
Finasteodin is an oral preparation containing 1 mg / 5 mg of the substance Finasteride.
Finasteodin works by blocking an enzyme called Type II 5α-reductase which is responsible for converting the hormone testosterone into dihydrotestosterone (DHT).
This results in increased levels of testosterone and decreased levels of dihydrotestosterone. An overabundance of dihydrotestosterone has been implicated in benign prostatic hyperplasia (BPH) and prostate cancer.
The scalp of men with androgenetic alopecia (male pattern baldness) has also been found to contain increased amounts of DHT and miniaturized hair follicles compared with men who have a lot of hair. Finasteride reduces scalp concentrations of DHT and appears to interrupt a key factor in the development of androgenetic alopecia in those men who are genetically predisposed.
Finasteodin belongs to the class of medicines known as 5-alpha reductase inhibitors.
Finasteodin is used by bodybuilders and athletes for generally the same reasons that it is used within the medical establishment: to slow down or prevent male pattern baldness associated with Dihydrotestosterone (DHT), as well as to mitigate or prevent the possibility of benign prostate hyperplasia of the same cause. With the use of Testosterone – especially in high dosages – bodybuilders and athletes often encounter a distinct increase in the area of androgenic side effects, which can include: an increase in aggression, increase in bodily hair growth, oily skin, and acne, as well as the possibility of prostate enlargement and triggering male pattern baldness.
This is primarily the result of Testosterone converting into a much stronger androgen, Dihydrotestosterone (DHT). While Testosterone itself is moderately androgenic, DHT is several times stronger as a male androgen. Testosterone undergoes conversion (or more formally, reduction) into DHT by way of the enzyme known as 5-alpha reductase (5AR). This enzyme is present in high concentrations in tissues such as the scalp, prostate, and underneath the skin. When Testosterone circulates throughout the bloodstream and passes through these tissues, the 5AR enzyme will bind to a certain percentage of the Testosterone that is present, and reduce it into Dihydrotestosterone.
Finasteodin is an inhibitor of 5-alpha reductase, and this is method of activity that Finasteodin works through in the body. It is important to note that 5AR inhibitors like Finasteride are successful only in reducing or preventing the conversion of Testosterone into DHT, and it is effectively useless if the athlete or bodybuilder is using other anabolic steroids that completely avoid the 5AR enzyme (or anabolic steroids that are already derivatives of DHT). Bodybuilders and athletes will typically use Finasteride in cycles with moderate to high dosages of Testosterone.
